| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 30, 2018 | EXAS Exact Sciences Corp | Fallon John A. | Director | Sell | 2,373 | $58.86 | $139,674.78 | -6.6% | |
| Jul 30, 2018 | EXAS Exact Sciences Corp | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 8,984 | $57.78 | $519,095.52 | -21.7% | |
| Jul 26, 2018 | IQV Iqvia Holdings Inc. | Bousbib Ari64 | See Remarks | Sell | 368,640 | $122.09 | $45,007,257.60 | -31.9% | |
| Jul 26, 2018 | DHR Danaher Corp /de/ | Comas Daniel L | EVP &CFO | Sell | 77,407 | $103.93 | $8,044,778.17 | -22.3% | |
| Jul 26, 2018 | IMDX Insight Molecular Diagnostics Inc. | Andrews Ronald Asbury | Director | Buy | 17,482 | $0.00 | - | New | |
| Jul 26, 2018 | IMDX Insight Molecular Diagnostics Inc. | Redmond Cavan M. | Director | Buy | 52,447 | $0.00 | - | New | |
| Jul 26, 2018 | IQV Iqvia Holdings Inc. | Rittenmeyer Ronald A72 | Director | Sell | 7,680 | $122.41 | $940,108.80 | -11.5% | |
| Jul 26, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 90,000 | $5.06 | $455,205.63 | +0.1% | |
| Jul 26, 2018 | IMDX Insight Molecular Diagnostics Inc. | Arno Andrew | Director | Buy | 52,447 | $0.00 | - | New | |
| Jul 26, 2018 | IMDX Insight Molecular Diagnostics Inc. | Levine Mitchell S | Chief Financial Officer | Buy | 3,495 | $0.00 | - | New | |
| Jul 26, 2018 | IMDX Insight Molecular Diagnostics Inc. | Last Andrew J.49 | Director | Buy | 6,993 | $0.00 | - | New | |
| Jul 26, 2018 | IMDX Insight Molecular Diagnostics Inc. | Annett William | President And CEO | Buy | 3,500 | $0.00 | - | New | |
| Jul 26, 2018 | IMDX Insight Molecular Diagnostics Inc. | Hesterberg Lyndal K. | Sr VP, Research &Development | Buy | 874 | $0.00 | - | New | |
| Jul 25, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 60,000 | $5.47 | $328,248.25 | +0.2% | |
| Jul 24, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 55,000 | $5.60 | $307,769.26 | - | |
| Jul 24, 2018 | VCYT Veracyte, Inc. | Hall Christopher M | President And COO | Sell | 10,000 | $11.00 | $110,000.00 | -23.6% | |
| Jul 24, 2018 | CRL Charles River Laboratories International, Inc. | Molho Davide | President &COO | Sell | 18,773 | $125.00 | $2,346,625.00 | -52.3% | |
| Jul 24, 2018 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Chairman And CEO | Sell | 50 | $11.50 | $575.00 | - | |
| Jul 24, 2018 | DHR Danaher Corp /de/ | Lutz Robert S | Svp-chief Accounting Officer | Sell | 14,555 | $103.93 | $1,512,637.48 | -28.7% | |
| Jul 23, 2018 | CRL Charles River Laboratories International, Inc. | Molho Davide | President &COO | Sell | 11,600 | $125.00 | $1,450,000.00 | -34.4% | |
| Jul 23, 2018 | DHR Danaher Corp /de/ | Lalor Angela S | SVP, Human Resources | Sell | 9,074 | $102.72 | $932,099.43 | -20.0% | |
| Jul 23, 2018 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Chairman And CEO | Sell | 6,000 | $10.20 | $61,174.80 | -10.2% | |
| Jul 20, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 10,000 | $5.89 | $58,900.00 | +0.2% | |
| Jul 19, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 10,000 | $5.95 | $59,500.00 | +0.2% | |
| Jul 18, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 10,000 | $6.05 | $60,500.00 | +0.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.